-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B8ZAKvtNQbAn9dtYvnC2jMUk2ik7ed99S2s604JGsm1a+8QTZ4egNY1/zb8Pk4ei WzEpLpS8Vqg4T4KyeDxm6Q== 0000898432-01-000141.txt : 20010223 0000898432-01-000141.hdr.sgml : 20010223 ACCESSION NUMBER: 0000898432-01-000141 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010214 GROUP MEMBERS: DORSEY R. GARDNER GROUP MEMBERS: HOLLYBANK INVESTMENTS LP/ GROUP MEMBERS: THISTLE INVESTMENT LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOORE MEDICAL CORP CENTRAL INDEX KEY: 0000074691 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 221897821 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-07421 FILM NUMBER: 1544769 BUSINESS ADDRESS: STREET 1: PO BOX 1500 STREET 2: 389 JOHN DOWNEY DR CITY: NEW BRITAIN STATE: CT ZIP: 06050 BUSINESS PHONE: 2038263600 MAIL ADDRESS: STREET 1: 389 JOHN DOWNEY DRIVE STREET 2: 389 JOHN DOWNEY DRIVE CITY: NEW BRITAIN STATE: CT ZIP: 06050 FORMER COMPANY: FORMER CONFORMED NAME: OPTEL CORP DATE OF NAME CHANGE: 19850611 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HOLLYBANK INVESTMENTS LP/ CENTRAL INDEX KEY: 0000934299 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 043215509 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: KELSO INVESTMENT CO INC STREET 2: ONE INTERNATIONAL PLACE STE 2401 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6173105110 MAIL ADDRESS: STREET 1: KELSO INVESTMENT CO INC STREET 2: ONE INTERNATIONAL PLACE STE 2401 CITY: BOSTON STATE: MA ZIP: 02111 FORMER COMPANY: FORMER CONFORMED NAME: DOT HILL SYSTEMS CORP/NY DATE OF NAME CHANGE: 19990910 FORMER COMPANY: FORMER CONFORMED NAME: HOLLYBANK INVESTMENTS LP DATE OF NAME CHANGE: 19941219 SC 13G/A 1 0001.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-l(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (AMENDMENT NO. 3)* MOORE MEDICAL CORP. (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securities) 615795103 (CUSIP Number) JANUARY 1, 2001 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-l(b) /X/ Rule 13d-l(c) / / Rule 13d-l(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G - ----------------------- ------------------ CUSIP NO. 615795103 PAGE 2 OF 9 PAGES - ----------------------- ------------------ - -------------------------------------------------------------------------------- NAME OF REPORTING PERSON 1 SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Hollybank Investment, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ] (b)[X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF SHARES 391,200 BENEFICIALLY ----------------------------------------------------------------- OWNED BY EACH 6 SHARED VOTING POWER REPORTING PERSON 0 WITH ----------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 391,200 ----------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 391,200 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] SHARES - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 12.6% (See Note 1) - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Note 1 - This Percentage is based on 3,101,000 shares of Common Stock outstanding as of February 12, 2001. SCHEDULE 13G - ----------------------- ------------------ CUSIP NO. 615795103 PAGE 3 OF 9 PAGES - ----------------------- ------------------ - -------------------------------------------------------------------------------- NAME OF REPORTING PERSON 1 SS. OR I.R.S IDENTIFICATION NO. OF ABOVE PERSON Thistle Investment LLC - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF SHARES 21,900 BENEFICIALLY ----------------------------------------------------------------- OWNED BY EACH 6 SHARED VOTING POWER REPORTING PERSON 0 WITH ----------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 21,900 ----------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,900 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] SHARES - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.7% (See Note 1) - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON OO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Note 1 - This Percentage is based on 3,101,000 shares of Common Stock outstanding as of February 12, 2001. SCHEDULE 13G - ----------------------- ------------------ CUSIP NO. 615795103 PAGE 4 OF 9 PAGES - ----------------------- ------------------ - -------------------------------------------------------------------------------- NAME OF REPORTING PERSON 1 SS. OR I.R.S IDENTIFICATION NO. OF ABOVE PERSON Dorsey R. Gardner - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF SHARES 63,000 **Please refer to Item 4, Page 6 for disclaimer OWNED BY of beneficial ownership EACH ----------------------------------------------------------------- REPORTING PERSON 6 SHARED VOTING POWER WITH 0 ----------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 63,000 **Please refer to Item 4, Page 6 for disclaimer of beneficial ownership ----------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 63,000 **Please refer to Item 4, Page 6 for disclaimer of beneficial ownership - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [X] SHARES - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.03% (See Note 1) **Please refer to Item 4, Page 6 for disclaimer of beneficial ownership - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Note 1 - This Percentage is based on 3,101,000 shares of Common Stock outstanding as of February 12, 2001. SCHEDULE 13G - ----------------------- ------------------ CUSIP NO. 615795103 PAGE 5 OF 9 PAGES - ----------------------- ------------------ ITEM 1(A). NAME OF ISSUER: Moore Medical Corp., a Delaware Corporation (the "Company"). ITEM I(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: P.O. Box 1500, 389 John Downey Drive, New Britain, Connecticut 06050. ITEM 2(A). NAME OF PERSON FILING: The Persons filing this statement are Hollybank Investment, L.P., a Delaware limited partnership ("LP"), Thistle Investment LLC, a Delaware limited liability company ("LLC") and Dorsey R. Gardner, a general partner of LP and managing member of LLC ("Gardner"). ITEM 2(B). ADDRESS OF PRINCIPAL OFFICES OR, IF NONE, RESIDENCE: The business address of Gardner, LP and LLC is c/o Kelso Management Company, Inc., One International Place, Suite 2401, Boston, Massachusetts 02110. ITEM 2(C). CITIZENSHIP: Hollybank Investment, L.P. - Delaware Thistle Investment LLC - Delaware Dorsey R. Gardner - U.S.A. ITEM 2(D). TITLE OF CLASS OF SECURITIES: The title of the class of equity securities to which this statement relates is the shares of Common Stock, par value $0.01 per share (the "Shares"), of the Company. ITEM 2(E). CUSIP NUMBER: 615795103 SCHEDULE 13G - ----------------------- ------------------ CUSIP NO. 615795103 PAGE 6 OF 9 PAGES - ----------------------- ------------------ ITEM 3. IF THE STATEMENT IS BEING FILED PURSUANT TO RULE 13d-l(b), OR 13d-2(b) OR (c), CHECK WHETHER THE FILING PERSON IS A: (a)| | Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b)| | Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c)| | Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d)| | Investment company registered under Section 8 of the Investment Company Act of 1940 (15U.S.C. 80a-8); (e)| | An investment adviser in accordance with l3d-l(b)(I)(ii)(E); (f)| | An employee benefit plan or endowment fund in accordance with 13d- I (b)(I)(ii)(F); (g)| | A parent holding company or control person in accordance with 13d-l(b)(1)(ii)(G); (h)| | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813); (i)| | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j)| | Group, in accordance with l3d-l(b)(l)(ii)(J). If this statement is filed pursuant to 13d-1(c), check this box. [X] ITEM 4. OWNERSHIP: The information in Items 5-11 on the cover pages (pages 2 through 4) of this Schedule 13G is incorporated by reference. As of the date of this statement, LP is the beneficial owner of 391,200 Shares and LLC is the beneficial owner of 21,900 Shares. Gardner, as a general partner of LP and managing member of LLC, may be deemed to beneficially own Shares beneficially owned by LP and LLC, respectively. Except to the extent of his interests as a limited partner in LP and a member of LLC, Gardner expressly disclaims such beneficial ownership and the filing of this statement shall not be construed as an admission that Gardner is the beneficial owner of the Shares owned by LP or LLC and covered by this statement. SCHEDULE 13G - ----------------------- ------------------ CUSIP NO. 615795103 PAGE 7 OF 9 PAGES - ----------------------- ------------------ ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person had ceased to be the beneficial owner of more than five percent of the class of securities, check the following | | ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not Applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not Applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not Applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not Applicable. ITEM 10. CERTIFICATION. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SCHEDULE 13G - ----------------------- ------------------ CUSIP NO. 615795103 PAGE 8 OF 9 PAGES - ----------------------- ------------------ SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 13, 2001 HOLLYBANK INVESTMENT, L.P. By: /s/ DORSEY R. GARDNER --------------------------- General Partner THISTLE INVESTMENT LLC By: /s/ DORSEY R. GARDNER --------------------------- Managing Member DORSEY R. GARDNER /s/ DORSEY R. GARDNER ---------------------------- Dorsey R. Gardner The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. ATTENTION. INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001). SCHEDULE 13G - ----------------------- ------------------ CUSIP NO. 615795103 PAGE 9 OF 9 PAGES - ----------------------- ------------------ EXHIBIT INDEX 99.1 Joint Filing Agreement. Incorporated herein by reference to Exhibit 99.1 to Amendment No. 2 of Schedule 13G filed electronically with the Securities and Exchange Commission on January 13, 2000 (Accession No. 0000898432-00-000045). -----END PRIVACY-ENHANCED MESSAGE-----